OMER
Omeros Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +2.3% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | -1 | 26.88M | $255.76M | +8 | −9 |
| Q1 2026 | 78 | +7 | 23.56M | $249.21M | +9 | −2 |
| Q4 2025 | 71 | -2 | 30.19M | $466.97M | — | −2 |
| Q3 2025 | 17 | 0 | 17.59M | $72.13M | — | — |
| Q2 2025 | 14 | +1 | 14.04M | $42.12M | +1 | — |
| Q1 2025 | 10 | +1 | 6.15M | $50.54M | +1 | — |
| Q4 2024 | 9 | 0 | 4.83M | $47.77M | +1 | −1 |
| Q3 2024 | 8 | +1 | 3.34M | $13.26M | +1 | — |
| Q2 2024 | 7 | — | 3.21M | $13.02M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 4.45M | +9.9% | $18.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 3.35M | +1.9% | $13.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 3.35M | +1.9% | $13.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 3.35M | +1.9% | $13.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 1.99M | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 1.99M | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 1.99M | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 1.99M | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 1.99M | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 1.99M | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passief) | 1.54M | +12.1% | $6.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 1.54M | +12.1% | $6.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passief) | 1.24M | +3.3% | $5.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 1.01M | -39.0% | $4.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 1.01M | -39.0% | $4.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 933.31K | +39.3% | $3.83M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 832.31K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Marshall Wace ✦ | 464.18K | -37.4% | $1.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 36 | Marshall Wace ✦ | 464.18K | -37.4% | $1.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 37 | Millennium Management ✦ | 401.81K | +49.1% | $1.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 393.23K | +149.3% | $1.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 39 | Renaissance Technologies ✦ | 344.50K | -10.0% | $1.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 336.09K | — | $1.38M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 336.09K | — | $1.38M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Wellington Management ✦ | 194.45K | +19.0% | $797,233 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 43 | Wellington Management ✦ | 194.45K | +19.0% | $797,233 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 44 | Wellington Management ✦ | 194.45K | +19.0% | $797,233 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 89.53K | +16.6% | $368,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 21.31K | +53.7% | $87,355 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 21.31K | +53.7% | $87,355 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 21.31K | +53.7% | $87,355 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 21.31K | +53.7% | $87,355 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 50 | Fidelity (FMR) ✦ | 13.19K | +13.3% | $54,078 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 51 | Fidelity (FMR) ✦ | 13.19K | +13.3% | $54,078 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 4.17M aandelen, $8.90M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 906 aand · $17,305
Officer · 10.00K aand · $189,500
Director · 15.00K aand · $276,772
Officer · 5.00K aand · $84,750
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie